Document:

MDCO EX 10.33 12.31.2014

EXHIBIT 10.33
SECOND AMENDMENT TO THE CONSULTING AGREEMENT 
This Second Amendment (the "Amendment") to the Consulting Agreement is effective as of July 6, 2013 (the "Amendment Effective Date"), by and between THE MEDICINES COMPANY, a De1aware corporation with its principal place of business located at 8 Sylvan Way, Parsippany, New Jersey 07054 (the "Company") and STRATEGIC IMAGERY, LLC, having an address of 315 South Shore Drive, Sarasota, Florida 34234 (the "Consultant"). The Company and the Consultant shall, at times throughout this Amendment, be referred to individually as a "Party" and collectively as the "Parties". 
WHEREAS, the Parties are parties to a certain Consulting Agreement, dated as of July 6, 2012, as amended (the "Original Agreement"); and 
WHEREAS, the Parties desire to amend the Original Agreement as more particularly set forth herein. 
NOW, THEREFORE, in consideration of the premises and the covenants and agreements contained in this Amendment, and for other good and valuable consideration, the Parties agree that, as of the Amendment Effective Date, the Original Agreement is amended as follows: 
1. Section 3.1 of the Original Agreement is hereby deleted in its entirety and replaced with the following: 
		
	3.1 
	The date this Agreement is signed by the last party to sign it (as indicated by the date associated with that party's signature) will be deemed the effective date of this Agreement (the "Effective Date"). If a Party signs fails to date a signature, the date that the other party receives the signing Party's signature will be deemed to be the date that the signing Party signed this agreement, and the other Party may inscribe that date as the date associated with the signing Party’s signature. This Agreement will continue until July 6, 2014 (the "Term"). Thereafter, this Agreement shall be subject to renewal for successive periods, upon the further written agreement of the Parties. 

2. Section 4.1 of the Original Agreement is hereby de1eted in its entirety and replaced with the following: 
		
	4.1 
	During the Term of this Agreement, the Company will pay the Consultant hour1y consulting fees in the amount of $500. The total amount payable for the Services under this Agreement shall not exceed in excess of$120,000 during any period of twelve consecutive months without prior written authorization from Company. The Company' s payment of the fees specified in this Agreement constitutes full payment to Consultant for the Services and Consultant shall not receive any other compensation or benefits for the Services. If, however, the Company requests a modification of the Services, the Parties shall agree in writing to adjust the fee accordingly. 

2. Capitalized terms used herein but not otherwise defined in this Amendment shall have the meanings provided in the Original Agreement. 

3.   Except as modified in this Amendment, the remainder of the Original Agreement shall remain in effect. This Amendment shall be deemed to be part of the Original Agreement and, as modified in accordance herewith, the Original Agreement is hereby ratified and declared in full force and effect. 

[Remainder of page intentionally left blank]

IN WITNESS WHEREOF, each Party has caused this Amendment to be executed by their respective duly authorized representative as of the date set forth above. 

THE MEDICINES COMPANY

By:    /s/ Clive A. Meanwell
Name:    Clive A. Meanwell
Title:    Chairman and Chief Executive Officer

STRATEGIC IMAGERY, LLC

By:    /s/ Robert G. Savage
Name:    Robert G. Savage
Title:    PresidentMDCO EX 10.34 12.31.2014

EXHIBIT 10.34

THIRD AMENDMENT TO THE CONSULTING AGREEMENT 

THIS Third Amendment (the “Amendment”) to the Consulting Agreement is effective as of July 7, 2014 (the “Amendment Effective Date”), by and between THE MEDICINES COMPANY, a Delaware corporation with its principal place of business located at 8 Sylvan Way, Parsippany, New Jersey 07054 (the “Company”) and STRATEGIC IMAGERY, LLC, having an address of 2604 North Greenway Drive, Coral Gables, Florida 33134 (“the Consultant”).  The Company and Consultant may at times throughout this Amendment be referred to individually as a “Party” and collectively as the “Parties”.

WHEREAS, the Parties entered into a certain Consulting Agreement dated as of July 6, 2012, as amended by the First Amendment dated December 3, 2012, and the Second Amendment dated July 6, 2013 (as amended, the “Agreement”); and

WHEREAS, the Parties desire to amend the Agreement with the Amendment as more particularly set forth herein.

NOW, THEREFORE, in consideration of the premises and the covenants and agreements contained herein, and for other good and valuable consideration, the parties agree as follows:

1.The Parties hereby agree to a one year renewal term of the Agreement, commencing July 7, 2014 and continuing until July 6, 2015, unless earlier terminated pursuant to the terms of the Agreement.

2.Section 4.3 of the Agreement is hereby deleted in its entirety and replaced with the following: 

		
	4.3
	Unless otherwise agreed to in writing by the Parties, Consultant shall invoice Company on a monthly basis for fees and expenses for the Services performed using the form of invoice attached hereto as Exhibit A. Such invoices shall include a detailed description of the Services rendered and the time spent in performance of those Services. Company agrees to pay Consultant invoices within forty-five (45) days of receipt. Unless indicated otherwise in a particular Scope of Services, Consultant shall submit such invoices for payment to the following address:

The Medicines Company
8 Sylvan Way
Parsippany, New Jersey 07054
Attn:    Accounts Payable
Email:    ap@themedco.com

3.Except as modified in this Amendment, the remainder of the Agreement shall remain in effect. This Amendment is considered to be part of the Agreement and, as modified in accordance herewith, the Agreement is hereby ratified and declared in full force and effect.

IN WITNESS WHEREOF, the parties have executed this Amendment as of the first day of the Renewal Term.

THE MEDICINES COMPANY                 STRATEGIC IMAGERY, LLC

By:    /s/ Stephen Rodin                    By: /s/ Robert G. Savage
Name:    Stephen Rodin                        Name:    Robert G. Savage
Title:    SVP and General Counsel                Title:    President
Date:  10-9-14                            Date:  10/21/14Exhibit 10.37

 

AMENDMENT OF OPTION AGREEMENT

 

This Amendment to Option Agreement (“Amendment”) is entered into as of November 15, 2014 by and between Mission Broadcasting, Inc. (“Mission”) and Nexstar Broadcasting, Inc. (“Nexstar”).  Each of Mission and Nexstar may be referred to herein as a “party” and collectively as the “parties.”

 

WHEREAS, Mission is the Federal Communications Commission (“FCC”) licensee of television broadcast station WFXP, Erie, Pennsylvania (the “Station”).

 

WHEREAS, Nexstar, Mission and David S. Smith are parties to that certain Option Agreement dated as of December 1, 2005, which outlines the terms and conditions upon which Nexstar may purchase from Mission the assets of the Station consistent with the rules and written policies of the FCC (the “Option Agreement”).  Capitalized terms not otherwise defined herein shall have the meaning assigned to such terms in the Option Agreement.

 

WHEREAS, Mr. Smith passed away on March 28, 2011 and the parties desire to amend the Option Agreement to remove Mr. Smith as a party to the Option Agreement. 

 

WHEREAS, the Option Agreement’s expiration date is the ninth anniversary of the Option Agreement (e.g., November 30, 2014).

 

WHEREAS, the parties desire to extend the Option Agreement for an additional nine (9) year term.

 

WHEREAS, the parties desire to amend certain other terms of the agreement as set forth herein.

 

NOW THEREFORE, in consideration of the foregoing and other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the parties agree as follows:

 

	
1.
	
Removal of David S. Smith.  The parties hereby agree that David S. Smith is deemed removed as a party to the Option Agreement.

 

	
2.
	
Option Expiration Date.  The parties hereby agree to extend the expiration date of the Option Agreement to November 30, 2023.

 

	
3.
	
Notices.   Paragraph 10.6 is hereby revised to update the addresses for delivery of Notices to both parties as follows:

 

To Mission:Mission Broadcasting, Inc.
30400 Detroit Road, Suite 304
Westlake, OH 44145
Attention: Dennis Thatcher

With a copy (which shall not constitute notice) to:

Wiley Rein LLP

1776 K Street, NW

Washington, D.C. 20006

Attention:  Richard Bodorff

 

To Nexstar:

	

	
Nexstar Broadcasting, Inc.
545 E. John Carpenter Freeway
Suite 700
Irving, TX  75062
Attention: Perry Sook, President & CEO

With a copy (which shall not constitute notice) to:

Armand Della Monica, Esq.

Kirkland & Ellis

Citicorp Center

153 East 53rd Street

New York, NY  10022-4675

	
4.
	
No Other Amendment.  No terms of the Option Agreement, other than the Option Expiration Date, are amended or modified by this Amendment, and the Option Agreement, as so extended hereby, remains in full force and effect.

 

IN WITNESS WHEREOF, the parties have executed this Amendment as of the day and year first written above.

 

		
	
MISSION BROADCASTING, INC.

 

 

 

By:/s/ Dennis Thatcher

     Dennis Thatcher

     President

 

 
	
NEXSTAR BROADCASTING, INC.

 

 

 

By:/s/ Elizabeth Ryder

     Elizabeth Ryder

     Senior Vice President & General CounselMYL_EX10.57_2014.12.31-10K

Exhibit 10.57
	
		
	 
	

	 
	1000 Mylan Boulevard
Canonsburg, PA 15317 USA
Phone    724.514.1800
Fax    724.514.1870
Web    mylan.com

Transition and Succession Agreement
Waiver Letter

Dear [l]:

Reference is made to your Transition and Succession Agreement with Mylan Inc. (the “Company”), as such agreement has been and may be amended from time to time (the “T&S Agreement”).  The T&S Agreement provides for the possibility of enhanced benefits or rights following a Change in Control of the Company (as such term is defined in the T&S Agreement).  By executing this waiver letter, for good and valuable consideration (including your continued employment and continued participation in the Company’s incentive plans and programs), you acknowledge and agree that the transactions consummated pursuant to the Business Transfer Agreement and Plan of Merger, dated as of July 13, 2014, by and among Abbott Laboratories, an Illinois corporation, the Company and the other parties thereto, as such agreement may be amended from time to time, shall not constitute a Change in Control for any purpose of the T&S Agreement.  All other provisions of the T&S Agreement, as modified by the foregoing, shall remain in full force and effect notwithstanding this waiver letter.

	
		
	MYLAN INC.,

	by

	 
	 

	 
	Name:   

	 
	Title:   

Acknowledged and agreed:

_____________________________
Name:

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00241-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00241-of-00352.parquet"}], [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00241-of-00352.parquet"}], [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00241-of-00352.parquet"}]]